Medistim ASA - Asset Resilience Ratio
Medistim ASA (MEDI) has an Asset Resilience Ratio of 29.72% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Medistim ASA PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2021)
This chart shows how Medistim ASA's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Medistim ASA to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Medistim ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MEDI market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr183.45 Million | 29.72% |
| Short-term Investments | Nkr0.00 | 0% |
| Total Liquid Assets | Nkr183.45 Million | 29.72% |
Asset Resilience Insights
- Very High Liquidity: Medistim ASA maintains exceptional liquid asset reserves at 29.72% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Medistim ASA Industry Peers by Asset Resilience Ratio
Compare Medistim ASA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
Annual Asset Resilience Ratio for Medistim ASA (2016–2021)
The table below shows the annual Asset Resilience Ratio data for Medistim ASA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 32.11% | Nkr129.49 Million ≈ $13.63 Million |
Nkr403.24 Million ≈ $42.43 Million |
+11.32pp |
| 2020-12-31 | 20.79% | Nkr71.89 Million ≈ $7.57 Million |
Nkr345.82 Million ≈ $36.39 Million |
+0.93pp |
| 2019-12-31 | 19.86% | Nkr66.75 Million ≈ $7.02 Million |
Nkr336.11 Million ≈ $35.37 Million |
+2.24pp |
| 2018-12-31 | 17.62% | Nkr47.49 Million ≈ $5.00 Million |
Nkr269.59 Million ≈ $28.37 Million |
-4.06pp |
| 2017-12-31 | 21.67% | Nkr54.41 Million ≈ $5.73 Million |
Nkr251.06 Million ≈ $26.42 Million |
+7.36pp |
| 2016-12-31 | 14.31% | Nkr31.07 Million ≈ $3.27 Million |
Nkr217.05 Million ≈ $22.84 Million |
-- |
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more